APO RESEARCH · REPORT
Circulating Tumor Cell (CTC) Detector
Circulating tumor cells (CTC) is generally referred to as the of all kinds of tumor cells in peripheral blood, lesions due to spontaneous or diagnosis and operation from solid tumors (primary tumors and metastases), most of CTCS in peripheral blood after apoptosis or be swallowed up, a few can escape and anchor the develop metastases, increase the risk of malignant tumor patients died.CTC circulating tumor cell detection equipment for the detection of isolated CTC circulating tumor cells.As new products continue to enter the market, the market competition is more and more fierce, the current industry's gross profit rate is very high, but with the technical requirements and policy restrictions, the product price will tend to be stable, the gross profit rate will gradually decline.As the global economy recovers and health awareness increases, the demand for circulating tumor cell detection systems will continue to increase, especially in underdeveloped regions such as the brics countries with large populations and fast economic growth.The demand will continue to rise. Secondly, Europe and the United States will export production capacity to developing countries. In the future, the production capacity of Asia will continue to increase.
Product & engineering
Understand the product.
Circulating tumor cells (CTC) is generally referred to as the of all kinds of tumor cells in peripheral blood, lesions due to spontaneous or diagnosis and operation from solid tumors (primary tumors and metastases), most of CTCS in peripheral blood after apoptosis or be swallowed up, a few can escape and anchor the develop metastases, increase the risk of malignant tumor patients died.CTC circulating tumor cell detection equipment for the detection of isolated CTC circulating tumor cells.As new products continue to enter the market, the market competition is more and more fierce, the current industry's gross profit rate is very high, but with the technical requirements and policy restrictions, the product price will tend to be stable, the gross profit rate will gradually decline.As the global economy recovers and health awareness increases, the demand for circulating tumor cell detection systems will continue to increase, especially in underdeveloped regions such as the brics countries with large populations and fast economic growth.The demand will continue to rise. Secondly, Europe and the United States will export production capacity to developing countries. In the future, the production capacity of Asia will continue to increase.
Selected research
Industry Research
Circulating Tumor Cell (CTC) Detector Industry Research Report 2026
Market perspective
Circulating tumor cells (CTC) is generally referred to as the of all kinds of tumor cells in peripheral blood, lesions due to spontaneous or diagnosis and operation from solid tumors (primary tumors and metastases), most of CTCS in peripheral blood after apoptosis or be swallowed up, a few can escape and anchor the develop metastases, increase the risk of malignant tumor patients died.CTC circulating tumor cell detection equipment for the detection of isolated CTC circulating tumor cells.As new products continue to enter the market, the market competition is more and more fierce, the current industry's gross profit rate is very high, but with the technical requirements and policy restrictions, the product price will tend to be stable, the gross profit rate will gradually decline.As the global economy recovers and health awareness increases, the demand for circulating tumor cell detection systems will continue to increase, especially in underdeveloped regions such as the brics countries with large populations and fast economic growth.The demand will continue to rise. Secondly, Europe and the United States will export production capacity to developing countries. In the future, the production capacity of Asia will continue to increase.
In China, Circulating Tumor Cell (CTC) Detector key players include YZYMED, NanoLite Systems, etc. Global top two manufacturers hold a share over 65%.
East China is the largest market, with a share about 25%, followed by South Central China, and North China, both have a share over 40 percent.
Read the full market overview
In terms of product, Domestic CTC is the largest segment, with a share over 80%. And in terms of application, the largest application is Clinical Application, followed by Scientific Research.
Report Scope
This report quantifies the global Circulating Tumor Cell (CTC) Detector market in terms of revenue (US$ million) and, where applicable, sales volume (Unit), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Unit) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Circulating Tumor Cell (CTC) Detector Market by Company
Celsee
YZYMED
NanoLite Systems
BGI
Watson Biotech
Circulating Tumor Cell (CTC) Detector Segment by Type
Import CTC
Domestic CTC
Circulating Tumor Cell (CTC) Detector Segment by Application
Clinical Application
Scientific Research
Circulating Tumor Cell (CTC) Detector Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circulating Tumor Cell (CTC) Detector market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Circulating Tumor Cell (CTC) Detector and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circulating Tumor Cell (CTC) Detector.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Circulating Tumor Cell (CTC) Detector manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Circulating Tumor Cell (CTC) Detector by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Circulating Tumor Cell (CTC) Detector in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Import CTC
- Domestic CTC
Applications
- Clinical Application
- Scientific Research
Companies covered
- Celsee
- YZYMED
- NanoLite Systems
- BGI
- Watson Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Circulating Tumor Cell (CTC) Detector Market Size (2021-2032)
- 2.2.2 Global Circulating Tumor Cell (CTC) Detector Sales (2021-2032)
- 2.2.3 Global Circulating Tumor Cell (CTC) Detector Market Average Price (2021-2032)
- 2.3 Circulating Tumor Cell (CTC) Detector by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Import CTC
- 2.3.3 Domestic CTC
- 2.4 Circulating Tumor Cell (CTC) Detector by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinical Application
- 2.4.3 Scientific Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Circulating Tumor Cell (CTC) Detector Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Circulating Tumor Cell (CTC) Detector Sales (Unit) of Manufacturers (2021-2026)
- 3.3 Global Circulating Tumor Cell (CTC) Detector Revenue of Manufacturers (2021-2026)
- 3.4 Global Circulating Tumor Cell (CTC) Detector Average Price by Manufacturers (2021-2026)
- 3.5 Global Circulating Tumor Cell (CTC) Detector Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Circulating Tumor Cell (CTC) Detector, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Circulating Tumor Cell (CTC) Detector, Product Type & Application
- 3.8 Global Manufacturers of Circulating Tumor Cell (CTC) Detector, Established Date
- 3.9 Global Circulating Tumor Cell (CTC) Detector Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Celsee
- 4.1.1 Celsee Company Information
- 4.1.2 Celsee Business Overview
- 4.1.3 Celsee Circulating Tumor Cell (CTC) Detector Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Celsee Circulating Tumor Cell (CTC) Detector Product Portfolio
- 4.1.5 Celsee Recent Developments
- 4.2 YZYMED
- 4.2.1 YZYMED Company Information
- 4.2.2 YZYMED Business Overview
- 4.2.3 YZYMED Circulating Tumor Cell (CTC) Detector Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 YZYMED Circulating Tumor Cell (CTC) Detector Product Portfolio
- 4.2.5 YZYMED Recent Developments
- 4.3 NanoLite Systems
- 4.3.1 NanoLite Systems Company Information
- 4.3.2 NanoLite Systems Business Overview
- 4.3.3 NanoLite Systems Circulating Tumor Cell (CTC) Detector Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 NanoLite Systems Circulating Tumor Cell (CTC) Detector Product Portfolio
- 4.3.5 NanoLite Systems Recent Developments
- 4.4 BGI
- 4.4.1 BGI Company Information
- 4.4.2 BGI Business Overview
- 4.4.3 BGI Circulating Tumor Cell (CTC) Detector Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BGI Circulating Tumor Cell (CTC) Detector Product Portfolio
- 4.4.5 BGI Recent Developments
- 4.5 Watson Biotech
- 4.5.1 Watson Biotech Company Information
- 4.5.2 Watson Biotech Business Overview
- 4.5.3 Watson Biotech Circulating Tumor Cell (CTC) Detector Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Watson Biotech Circulating Tumor Cell (CTC) Detector Product Portfolio
- 4.5.5 Watson Biotech Recent Developments
5 Global Circulating Tumor Cell (CTC) Detector Market Scenario by Region
- 5.1 Global Circulating Tumor Cell (CTC) Detector Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Circulating Tumor Cell (CTC) Detector Sales by Region: 2021-2032
- 5.2.1 Global Circulating Tumor Cell (CTC) Detector Sales by Region: 2021-2026
- 5.2.2 Global Circulating Tumor Cell (CTC) Detector Sales by Region: 2027-2032
- 5.3 Global Circulating Tumor Cell (CTC) Detector Revenue by Region: 2021-2032
- 5.3.1 Global Circulating Tumor Cell (CTC) Detector Revenue by Region: 2021-2026
- 5.3.2 Global Circulating Tumor Cell (CTC) Detector Revenue by Region: 2027-2032
- 5.4 North America Circulating Tumor Cell (CTC) Detector Market Facts & Figures by Country
- 5.4.1 North America Circulating Tumor Cell (CTC) Detector Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Circulating Tumor Cell (CTC) Detector Sales by Country (2021-2032)
- 5.4.3 North America Circulating Tumor Cell (CTC) Detector Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Circulating Tumor Cell (CTC) Detector Market Facts & Figures by Country
- 5.5.1 Europe Circulating Tumor Cell (CTC) Detector Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Circulating Tumor Cell (CTC) Detector Sales by Country (2021-2032)
- 5.5.3 Europe Circulating Tumor Cell (CTC) Detector Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Circulating Tumor Cell (CTC) Detector Market Facts & Figures by Country
- 5.6.1 Asia Pacific Circulating Tumor Cell (CTC) Detector Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Circulating Tumor Cell (CTC) Detector Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Circulating Tumor Cell (CTC) Detector Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Circulating Tumor Cell (CTC) Detector Market Facts & Figures by Country
- 5.7.1 South America Circulating Tumor Cell (CTC) Detector Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Circulating Tumor Cell (CTC) Detector Sales by Country (2021-2032)
- 5.7.3 South America Circulating Tumor Cell (CTC) Detector Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Circulating Tumor Cell (CTC) Detector Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Circulating Tumor Cell (CTC) Detector Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Circulating Tumor Cell (CTC) Detector Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Circulating Tumor Cell (CTC) Detector Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Circulating Tumor Cell (CTC) Detector Sales by Type (2021-2032)
- 6.1.1 Global Circulating Tumor Cell (CTC) Detector Sales by Type (2021-2032) & (Unit)
- 6.1.2 Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Type (2021-2032)
- 6.2 Global Circulating Tumor Cell (CTC) Detector Revenue by Type (2021-2032)
- 6.2.1 Global Circulating Tumor Cell (CTC) Detector Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Type (2021-2032)
- 6.3 Global Circulating Tumor Cell (CTC) Detector Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Circulating Tumor Cell (CTC) Detector Sales by Application (2021-2032)
- 7.1.1 Global Circulating Tumor Cell (CTC) Detector Sales by Application (2021-2032) & (Unit)
- 7.1.2 Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Application (2021-2032)
- 7.2 Global Circulating Tumor Cell (CTC) Detector Revenue by Application (2021-2032)
- 7.2.1 Global Circulating Tumor Cell (CTC) Detector Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Application (2021-2032)
- 7.3 Global Circulating Tumor Cell (CTC) Detector Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Circulating Tumor Cell (CTC) Detector Value Chain Analysis
- 8.1.1 Circulating Tumor Cell (CTC) Detector Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Circulating Tumor Cell (CTC) Detector Production Mode & Process
- 8.2 Circulating Tumor Cell (CTC) Detector Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Circulating Tumor Cell (CTC) Detector Distributors
- 8.2.3 Circulating Tumor Cell (CTC) Detector Customers
9 Global Circulating Tumor Cell (CTC) Detector Analyzing Market Dynamics
- 9.1 Circulating Tumor Cell (CTC) Detector Industry Trends
- 9.2 Circulating Tumor Cell (CTC) Detector Industry Drivers
- 9.3 Circulating Tumor Cell (CTC) Detector Industry Opportunities and Challenges
- 9.4 Circulating Tumor Cell (CTC) Detector Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst